REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilab Laboratorio Clinico Y Citologico Sas (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Unilab Laboratorio Clinico Y Citologico Sas Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unilab Laboratorio Clinico Y Citologico Sas is based in Colombia. The head office is in La union. It operates in the Diagnostic Imaging Centers industry. The company was established on October 02, 2015. The company’s latest financial report indicates a net sales revenue increase of 15.12% in 2023. There was a total growth of 4.51% in Unilab Laboratorio Clinico Y Citologico Sas’s total assets over the same period. The net profit margin of Unilab Laboratorio Clinico Y Citologico Sas decreased by 0.36% in 2023.

Headquarters
Cr 4 11 10 Brr San Antonio
La union; Narino;

Contact Details: Purchase the Unilab Laboratorio Clinico Y Citologico Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Unilab Laboratorio Clinico Y Citologico Sas report to view the information.
Incorporation Date:
October 02, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unilab Laboratorio Clinico Y Citologico Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15.12%
Total operating revenue
15.12%
Operating profit (EBIT)
23.05%
EBITDA
27.59%
Net Profit (Loss) for the Period
-17.34%
Total assets
4.51%
Total equity
0.29%
Operating Profit Margin (ROS)
0.93%
Net Profit Margin
-0.36%
Return on Equity (ROE)
-0.49%
Debt to Equity Ratio
5.26%
Quick Ratio
0.05%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?